migraine Clinical Trials and Research
Also known as: migraine headache, chronic migraine, episodic migraine, ocular migraine, migraine with aura, migraine without aura · ICD-10: G43
Migraine is a neurological condition causing severe headaches, often accompanied by throbbing pain, nausea, and sensitivity to light or sound. Clinical trial research is focused on developing new treatments, prevention methods, and understanding its underlying mechanisms. Find a Trial helps patients search for active studies.
Common questions about migraine clinical trials
Who can participate in migraine clinical trials?
Eligibility criteria vary by study, often including age, migraine type, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data. Information is available on ClinicalTrials.gov.
What are the different phases of migraine clinical trials?
Clinical trials typically progress through phases 1 to 4. Early phases test safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones. Data is often found on ClinicalTrials.gov.
Do participants have to pay to join a migraine clinical trial?
Generally, participants do not pay to join a clinical trial. Study sponsors usually cover research-related costs, including study medications and procedures. Patients should clarify any potential costs with the research team.
What are current research directions for migraine treatments?
Current research explores new drug targets, such as CGRP pathway inhibitors, and non-pharmacological interventions like neuromodulation devices. Researchers are also investigating genetic factors and personalized treatment approaches, as reported on NIH RePORTER and ClinicalTrials.gov.
What types of interventions are studied in migraine trials?
Interventions include new oral medications, injectable therapies, medical devices for nerve stimulation, and behavioral therapies. Studies often compare these new approaches to placebos or standard care to assess their effectiveness and safety.
Are there specific biomarkers used in migraine research?
Researchers are investigating various biomarkers, including genetic markers, inflammatory molecules, and neuroimaging findings, to better understand migraine mechanisms. These may help predict treatment response or identify individuals at higher risk, as seen in studies on NIH RePORTER.
What might prevent someone from joining a migraine study?
Common exclusion criteria can include certain co-existing medical conditions, use of specific medications, pregnancy, or a history of drug abuse. These criteria help ensure patient safety and the integrity of study results.
Are there clinical trials focusing on migraine prevention?
Yes, many clinical trials are dedicated to developing and testing new preventive treatments for migraine. These studies aim to reduce the frequency, severity, and duration of migraine attacks. Information on such trials is available on ClinicalTrials.gov.
How to find a migraine trial that fits you
- Describe your migraine situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.